Only 10% of patients in their cohort had cavitary disease, but those with CD4 <200 cells/mm3 were significantly less likely to have cavities and more likely to have hilar/mediastinal lymphadenopathy. This evidence concerns the gene CD4 and Lymphadenopathy.